CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
51.23
-0.75 (-1.44%)
Feb 5, 2026, 11:34 AM EST - Market open
CG Oncology Market Cap
CG Oncology has a market cap or net worth of $4.13 billion as of February 5, 2026. Its market cap has increased by 80.94% in one year.
Market Cap
4.13B
Enterprise Value
3.52B
1-Year Change
80.94%
Ranking
Category
Stock Price
$51.23
Market Cap Chart
Since the IPO on January 25, 2024, CG Oncology's market cap has increased from $1.21B to $4.13B, an increase of 242.62%. That is a compound annual growth rate of 83.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 4, 2026 | 4.19B | 25.19% |
| Dec 31, 2025 | 3.35B | 53.40% |
| Dec 31, 2024 | 2.18B | 81.02% |
| Jan 25, 2024 | 1.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apogee Therapeutics | 4.65B |
| Amicus Therapeutics | 4.48B |
| TG Therapeutics | 4.35B |
| Corcept Therapeutics | 4.28B |
| Terns Pharmaceuticals | 4.19B |
| ACADIA Pharmaceuticals | 4.19B |
| ADMA Biologics | 4.17B |
| Liquidia | 4.06B |